Colgate-Palmolive (NYSE:CL) Given New $112.00 Price Target at Piper Sandler

Colgate-Palmolive (NYSE:CL) had its price objective reduced by Piper Sandler from $121.00 to $112.00 in a research report sent to investors on Monday,Benzinga reports. They currently have an overweight rating on the stock.

Other research analysts have also issued reports about the company. StockNews.com upgraded Colgate-Palmolive from a “hold” rating to a “buy” rating in a research note on Wednesday, January 1st. TD Cowen cut their price target on shares of Colgate-Palmolive from $115.00 to $110.00 and set a “buy” rating for the company in a report on Monday, October 28th. Stifel Nicolaus cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $105.00 to $101.00 in a research note on Monday, October 28th. Deutsche Bank Aktiengesellschaft cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and lifted their target price for the company from $107.00 to $109.00 in a research note on Monday, September 9th. Finally, Wells Fargo & Company reduced their target price on Colgate-Palmolive from $100.00 to $92.00 and set an “underweight” rating on the stock in a report on Monday, October 28th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have given a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $104.63.

Colgate-Palmolive Stock Down 3.0 %

Shares of CL opened at $87.42 on Monday. Colgate-Palmolive has a 12 month low of $79.69 and a 12 month high of $109.30. The stock has a market cap of $71.42 billion, a price-to-earnings ratio of 25.05, a P/E/G ratio of 3.31 and a beta of 0.44. The company has a 50-day moving average price of $93.18 and a two-hundred day moving average price of $98.38. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46.

Colgate-Palmolive Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be given a $0.50 dividend. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.29%. Colgate-Palmolive’s dividend payout ratio is 57.31%.

Insider Buying and Selling at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the sale, the chief financial officer now directly owns 36,726 shares in the company, valued at $3,456,283.86. This represents a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 0.34% of the company’s stock.

Institutional Trading of Colgate-Palmolive

A number of large investors have recently bought and sold shares of CL. Reston Wealth Management LLC acquired a new stake in shares of Colgate-Palmolive during the third quarter worth $42,000. Capital Performance Advisors LLP bought a new stake in shares of Colgate-Palmolive in the third quarter valued at about $53,000. Prospera Private Wealth LLC bought a new stake in shares of Colgate-Palmolive in the third quarter valued at about $64,000. True Wealth Design LLC grew its holdings in shares of Colgate-Palmolive by 1,460.9% during the third quarter. True Wealth Design LLC now owns 718 shares of the company’s stock worth $75,000 after buying an additional 672 shares in the last quarter. Finally, Continuum Advisory LLC grew its holdings in shares of Colgate-Palmolive by 93.4% during the third quarter. Continuum Advisory LLC now owns 762 shares of the company’s stock worth $79,000 after buying an additional 368 shares in the last quarter. 80.41% of the stock is owned by institutional investors.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.